SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)
Italy
· Delayed Price · Currency is EUR 29.70
0.00 (0.00%)
At close: Jun 20, 2025, 5:30 PM CET
BIT:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 252.33M EUR in the quarter ending March 31, 2025, with 7.74% growth. This brings the company's revenue in the last twelve months to 972.81M, up 6.16% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.
Revenue (ttm)
972.81M
Revenue Growth
+6.16%
P/S Ratio
4.38
Revenue / Employee
203.09K
Employees
4,690
Market Cap
4.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UniCredit | 24.19B |
| Intesa Sanpaolo | 25.43B |
| Enel SpA | 78.35B |
| Ferrari | 6.88B |
| Assicurazioni Generali | 55.30B |
| Eni S.p.A. | 90.96B |
| Leonardo S.p.a. | 18.26B |
| Stellantis | 156.88B |